ViaDerma, Inc. (OTCMKTS:VDRM) Short Interest Update
ViaDerma, Inc. (OTCMKTS:VDRM) Short Interest Update
ViaDerma, Inc. (OTCMKTS:VDRM – Get Rating) was the recipient of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 48,900 shares, a decrease of 93.4% from the February 28th total of 745,900 shares. Based on an average trading volume of 14,181,700 shares, the short-interest ratio is presently 0.0 days.
ViaDerma, Inc.（場外交易股票代碼：VDRM — 獲取評級）是3月份空頭利率大幅下降的受益者。截至3月15日，空頭利息總額爲48,900股，較2月28日的745,900股下降了93.4％。根據14,181,700股的平均交易量，空頭利率目前爲0.0天。
ViaDerma Trading Up 7.6 %
ViaDerma 交易價格上漲 7.6%
Shares of OTCMKTS:VDRM opened at 0.03 on Tuesday. The business's fifty day moving average price is 0.01 and its two-hundred day moving average price is 0.01. ViaDerma has a fifty-two week low of 0.00 and a fifty-two week high of 0.03.
OTCMKTS: VDRM的股票週二開盤價爲0.03。該企業的五十天移動平均價格爲0.01，其兩百天移動平均價格爲0.01。ViaDerma的五十二週低點爲0.00，五十二週高點爲0.03。
About ViaDerma
關於 ViaDerma
(Get Rating)
（獲取評級）
ViaDerma, Inc is engaged in the manufacturing and sales of pharmaceutical related products. The company was founded on January 11, 2007 and is headquartered in Marina Del Rey, CA.
ViaDerma, Inc從事藥品相關產品的製造和銷售。該公司成立於2007年1月11日，總部位於加利福尼亞州瑪麗娜德爾雷。
Featured Stories
精選故事
- Get a free copy of the StockNews.com research report on ViaDerma (VDRM)
- 3 High Yields On Breakout Watch With Analyst Tailwinds
- Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
- 3 Financials The Insiders Are Buying
- Can Carnival Cruise Lines Set Sail For New Highs?
- If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
- 免費獲取 StockNews.com 關於 ViaDerma (VDRM) 的研究報告
- 分析師利好在突破觀察中收穫3高收益率
- 賽諾菲、Regeneron在有關慢性阻塞性肺病治療的重大新聞中股價大漲
- 業內人士正在買入的 3 種金融產品
- 嘉年華郵輪公司能否啓航創下新高？
- 如果你關心安全，那就去桑迪斯普林銀行看看
Receive News & Ratings for ViaDerma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ViaDerma and related companies with MarketBeat.com's FREE daily email newsletter.
接收ViaDerma Daily的新聞和評級——在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收有關ViaDerma及相關公司的最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。